Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 188

1.

Correction to "Display Selection of Exotic Macrocyclic Peptides Expressed Under a Radically Reprogrammed 23 Amino Acid Genetic Code".

Passioura T, Liu W, Dunkelmann D, Higuchi T, Suga H.

J Am Chem Soc. 2019 Jul 24;141(29):11727-11728. doi: 10.1021/jacs.9b06806. Epub 2019 Jul 9. No abstract available.

PMID:
31287675
2.

Generation of non-standard macrocyclic peptides specifically binding TSC-22 homologous gene-1.

Tran STP, Hipolito CJ, Suzuki H, Xie R, Kim Tuyen HD, Dijke PT, Terasaka N, Goto Y, Suga H, Kato M.

Biochem Biophys Res Commun. 2019 Aug 20;516(2):445-450. doi: 10.1016/j.bbrc.2019.06.035. Epub 2019 Jun 18.

PMID:
31227214
3.

De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains.

Nawatha M, Rogers JM, Bonn SM, Livneh I, Lemma B, Mali SM, Vamisetti GB, Sun H, Bercovich B, Huang Y, Ciechanover A, Fushman D, Suga H, Brik A.

Nat Chem. 2019 Jul;11(7):644-652. doi: 10.1038/s41557-019-0278-x. Epub 2019 Jun 10.

PMID:
31182821
4.

Optimizing aromatic oligoamide foldamer side-chains for ribosomal translation initiation.

Tsiamantas C, Kwon S, Douat C, Huc I, Suga H.

Chem Commun (Camb). 2019 Jun 20;55(51):7366-7369. doi: 10.1039/c9cc03547h.

PMID:
31172994
5.

A Case Study on the Keap1 Interaction with Peptide Sequence Epitopes Selected by the Peptidomic mRNA Display.

Hirose H, Hideshima T, Katoh T, Suga H.

Chembiochem. 2019 Aug 16;20(16):2089-2100. doi: 10.1002/cbic.201900039. Epub 2019 Jun 6.

PMID:
31169361
6.

Discovery of Functional Macrocyclic Peptides by Means of the RaPID System.

Tsiamantas C, Otero-Ramirez ME, Suga H.

Methods Mol Biol. 2019;2001:299-315. doi: 10.1007/978-1-4939-9504-2_14.

PMID:
31134577
7.

Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor.

Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S, Zouda M, Watanabe Y, Yano S, Shibata M, Suga H, Matsumoto K.

Nat Chem Biol. 2019 Jun;15(6):598-606. doi: 10.1038/s41589-019-0285-7. Epub 2019 May 17.

PMID:
31101918
8.

Exploring the Minimal RNA Substrate of Flexizymes.

Fujino T, Kondo T, Suga H, Murakami H.

Chembiochem. 2019 Aug 1;20(15):1959-1965. doi: 10.1002/cbic.201900150. Epub 2019 Jun 26.

PMID:
30950544
9.

Flexizyme-catalyzed synthesis of 3'-aminoacyl-NH-tRNAs.

Katoh T, Suga H.

Nucleic Acids Res. 2019 May 21;47(9):e54. doi: 10.1093/nar/gkz143.

10.

De Novo Discovery of Nonstandard Macrocyclic Peptides as Noncompetitive Inhibitors of the Zika Virus NS2B-NS3 Protease.

Nitsche C, Passioura T, Varava P, Mahawaththa MC, Leuthold MM, Klein CD, Suga H, Otting G.

ACS Med Chem Lett. 2019 Jan 4;10(2):168-174. doi: 10.1021/acsmedchemlett.8b00535. eCollection 2019 Feb 14.

PMID:
30783498
11.

Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges.

Vinogradov AA, Yin Y, Suga H.

J Am Chem Soc. 2019 Mar 13;141(10):4167-4181. doi: 10.1021/jacs.8b13178. Epub 2019 Feb 27.

PMID:
30768253
12.

Chemical and Ribosomal Synthesis of Topologically Controlled Bicyclic and Tricyclic Peptide Scaffolds Primed by Selenoether Formation.

Yin Y, Fei Q, Liu W, Li Z, Suga H, Wu C.

Angew Chem Int Ed Engl. 2019 Apr 1;58(15):4880-4885. doi: 10.1002/anie.201813827. Epub 2019 Mar 12.

PMID:
30762292
13.

Engineering Translation Components Improve Incorporation of Exotic Amino Acids.

Katoh T, Suga H.

Int J Mol Sci. 2019 Jan 26;20(3). pii: E522. doi: 10.3390/ijms20030522. Review.

14.

Ribosomal Synthesis of Backbone-Cyclic Peptides Compatible with In Vitro Display.

Takatsuji R, Shinbara K, Katoh T, Goto Y, Passioura T, Yajima R, Komatsu Y, Suga H.

J Am Chem Soc. 2019 Feb 13;141(6):2279-2287. doi: 10.1021/jacs.8b05327. Epub 2019 Feb 1.

PMID:
30648857
15.

Flexizyme-Enabled Benchtop Biosynthesis of Thiopeptides.

Fleming SR, Bartges TE, Vinogradov AA, Kirkpatrick CL, Goto Y, Suga H, Hicks LM, Bowers AA.

J Am Chem Soc. 2019 Jan 16;141(2):758-762. doi: 10.1021/jacs.8b11521. Epub 2019 Jan 8.

16.

Corrigendum to "Structure-activity studies of a macrocyclic peptide inhibitor of histone lysine demethylase 4A" [Bioorg. Med. Chem. 26/6 (2018) 1225-1231].

Passioura T, Bhushan B, Tumber A, Kawamura A, Suga H.

Bioorg Med Chem. 2019 Feb 1;27(3):578. doi: 10.1016/j.bmc.2018.12.020. Epub 2018 Dec 26. No abstract available.

PMID:
30594451
17.

Structural Features and Binding Modes of Thioether-Cyclized Peptide Ligands.

Otero-Ramirez ME, Passioura T, Suga H.

Biomedicines. 2018 Dec 13;6(4). pii: E116. doi: 10.3390/biomedicines6040116. Review.

18.

In vitro expression of genetically encoded non-standard peptides consisting of exotic amino acid building blocks.

Hirose H, Tsiamantas C, Katoh T, Suga H.

Curr Opin Biotechnol. 2018 Nov 16;58:28-36. doi: 10.1016/j.copbio.2018.10.012. [Epub ahead of print] Review.

PMID:
30453154
19.

Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist.

Miao W, Sakai K, Ozawa N, Nishiuchi T, Suzuki Y, Ito K, Morioka T, Umitsu M, Takagi J, Suga H, Matsumoto K.

Sci Rep. 2018 Nov 7;8(1):16492. doi: 10.1038/s41598-018-34835-4.

20.

RNA Display Methods for the Discovery of Bioactive Macrocycles.

Huang Y, Wiedmann MM, Suga H.

Chem Rev. 2018 Nov 5. doi: 10.1021/acs.chemrev.8b00430. [Epub ahead of print]

PMID:
30395448

Supplemental Content

Loading ...
Support Center